FGF-2– and TGF-β1–Induced Downregulation of Lumican and Keratocan in Activated Corneal Keratocytes by JNK Signaling Pathway
Open Access
- 1 November 2011
- journal article
- cornea
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 52 (12) , 8957-8964
Abstract
Purpose.: Downregulation of lumican and keratocan expression is an undesirable phenotypic change that occurs during corneal wound healing. The present study was intended to determine whether the activation of Jun N-terminal kinase (JNK)-signaling pathway is involved in their downregulation in TGF-β1– and FGF-2–activated keratocytes. Methods.: Keratocytes, isolated from rabbit corneal stroma, and cultured in a serum-free medium, pretreated or not treated with JNK inhibitor (SP600125), were activated with FGF-2/heparin sulfate (HS) or TGF-β1 in the presence or absence of SP600125. In another set of experiments, keratocytes were transfected with JNK1/2 Dicer-substrate RNA (DsiRNA) and then activated with TGF-β1 or FGF-2/HS. Specific phenotypic changes were analyzed immunocytochemically and correlated with Western blot analyses. The relative levels of specific mRNAs were estimated by quantitative RT-PCR using specific reagents. Results.: The FGF-2/HS– or TGF-β–induced activation of corneal stromal keratocytes to fibroblast- or myofibroblast-phenotype, respectively, resulted in marked decreases in cell surfaceassociated and secreted keratan sulfate proteoglycans (KSPGs). Both keratocan and lumican proteins and their mRNAs were downregulated in the activated keratocytes. However, JNK inhibition during the activation of keratocytes, pretreated with the JNK inhibitor, suppressed the reduction in the cell–surface associated and secreted KSPGs (lumican and keratocan), and their mRNA transcripts. Downregulation of total KSPGs and their mRNAs was also inhibited by decreasing JNK1 and JNK2 levels via JNK1/2 DsiRNA transfection of keratocytes before their activation. Conclusions.: Extrapolating from the present study, FGF-2– and TGF-β1–activation of JNK signaling pathway may be partly responsible for the downregulation of keratocan and lumican expression in activated corneal keratocytes observed during corneal stromal wound healing.Keywords
This publication has 36 references indexed in Scilit:
- Rho‐kinase mediates lysophosphatidic acid‐induced IL‐8 and MCP‐1 production via p38 and JNK pathways in human endothelial cellsFEBS Letters, 2010
- Rho-Mediated Regulation of TGF-β1– and FGF-2–Induced Activation of Corneal Stromal KeratocytesInvestigative Ophthalmology & Visual Science, 2009
- C-Jun NH2 terminal kinase (JNK) is an essential mediator of Toll-like receptor 2-induced corneal inflammationJournal of Leukocyte Biology, 2008
- Rho/ROCK Signaling in Regulation of Corneal Epithelial Cell Cycle ProgressionInvestigative Ophthalmology & Visual Science, 2008
- Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodelingCurrent Opinion in Nephrology and Hypertension, 2007
- Loss of Alpha3(IV) Collagen Expression Associated with Corneal Keratocyte ActivationInvestigative Ophthalmology & Visual Science, 2007
- Collagen fibril assembly during postnatal development and dysfunctional regulation in the lumican‐deficient murine corneaDevelopmental Dynamics, 2006
- Keratocan-deficient Mice Display Alterations in Corneal StructureJournal of Biological Chemistry, 2003
- Synthesis of Corneal Keratan Sulfate Proteoglycans by Bovine Keratocytes in VitroJournal of Biological Chemistry, 1996
- Extracellular matrix and growth factors in corneal wound healingCurrent Opinion in Ophthalmology, 1996